Loading…
Reported covered position: Health Policy Advisor to Chief Deputy Whip and House Energy and Commerce Committee MemberRickLazio(R-NY)
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: SMILEDIRECTCLUB · Firm: THE VOGEL GROUP
Discussions regarding improving and strengthening access to telehealth;S.1512 - CONNECT for Health Act of 2021/H.R. 2903
Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2021
Client: SMILEDIRECTCLUB · Firm: THE VOGEL GROUP
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PSC BIOTECH via THE VOGEL GROUP
2021 · third_quarter · Q3
Issues around government funding
Filing targets: Agriculture, Dept of (USDA), Air Force, Dept of, Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DELOS LIVING, LLC via THE VOGEL GROUP
2021 · third_quarter · Q3
Source: Senate LDA
| CORIZON HEALTH |
| 4 |
| 2020 |
| MEDTRADE PRODUCTS LTD | 4 | 2020 |
| REALTA LIFE SCIENCES, INC. | 4 | 2020–2021 |
| PSC BIOTECH | 3 | 2021 |
| TERAGROUP | 2 | 2021 |
| MAX SCHACHTER | 1 | 2020 |
| SPECTRO SOLUTIONS, INC. | 1 | 2021 |
Discussions regarding improving and strengthening access to telehealth;S.1512 - CONNECT for Health Act of 2021/H.R. 2903
Discussions regarding improving and strengthening access to telehealth;S.1512 - CONNECT for Health Act of 2021/H.R. 2903
Discussions regarding improving and strengthening access to telehealth;S.1512 - CONNECT for Health Act of 2021/H.R. 2903
Orange Book Transparency Act of 2020
Client: NEPHRON PHARMACEUTICALS CORPORATION · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019, COVID-19 Response
Further Extension of Continuing Appropriations Act, 2021
Client: NEPHRON PHARMACEUTICALS CORPORATION · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019, COVID-19 Response
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019, COVID-19 Response
Preserve Access to Affordable Generics and Biosimilars Act
Client: NEPHRON PHARMACEUTICALS CORPORATION · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019, COVID-19 Response
Prescription Pricing for the People Act of 2019
Client: NEPHRON PHARMACEUTICALS CORPORATION · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019, COVID-19 Response
Threat Assessment, Prevention, and Safety Act of 2019
Client: MAX SCHACHTER · Firm: THE VOGEL GROUP
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Threat Assessment, Prevention, and Safety Act of 2019
Client: MAX SCHACHTER · Firm: THE VOGEL GROUP
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Threat Assessment, Prevention, and Safety Act of 2019
Client: MAX SCHACHTER · Firm: THE VOGEL GROUP
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Threat Assessment, Prevention, and Safety Act of 2019
Client: MAX SCHACHTER · Firm: THE VOGEL GROUP
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019, COVID-19 Response
Threat Assessment, Prevention, and Safety Act of 2019
Client: MAX SCHACHTER · Firm: THE VOGEL GROUP
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Threat Assessment, Prevention, and Safety Act of 2019
Client: MAX SCHACHTER · Firm: THE VOGEL GROUP
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Threat Assessment, Prevention, and Safety Act of 2019
Client: MAX SCHACHTER · Firm: THE VOGEL GROUP
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Threat Assessment, Prevention, and Safety Act of 2019
Client: MAX SCHACHTER · Firm: THE VOGEL GROUP
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Orange Book Transparency Act of 2020
Client: NEPHRON PHARMACEUTICALS CORPORATION · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Further Extension of Continuing Appropriations Act, 2021
Client: NEPHRON PHARMACEUTICALS CORPORATION · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Preserve Access to Affordable Generics and Biosimilars Act
Client: NEPHRON PHARMACEUTICALS CORPORATION · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Prescription Pricing for the People Act of 2019
Client: NEPHRON PHARMACEUTICALS CORPORATION · Firm: THE VOGEL GROUP
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Issues relating to pandemic response and indoor air quality
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, White House Office
SMILEDIRECTCLUB via THE VOGEL GROUP
2021 · third_quarter · Q3
Discussions regarding improving and strengthening access to telehealth;S.1512 - CONNECT for Health Act of 2021/H.R. 2903
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEPHRON PHARMACEUTICALS CORPORATION via THE VOGEL GROUP
2021 · third_quarter · Q3
Issues around government support for new manufacturing operations
Issues around pandemic response efforts and domestic manufacturing
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PSC BIOTECH via THE VOGEL GROUP
2021 · second_quarter · Q2
Issues around government funding
Filing targets: Agriculture, Dept of (USDA), Air Force, Dept of, Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DELOS LIVING, LLC via THE VOGEL GROUP
2021 · second_quarter · Q2
Issues relating to pandemic response and indoor air quality
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, White House Office
SMILEDIRECTCLUB via THE VOGEL GROUP
2021 · second_quarter · Q2
Discussions regarding improving and strengthening access to telehealth;S.1512 - CONNECT for Health Act of 2021/H.R. 2903
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEPHRON PHARMACEUTICALS CORPORATION via THE VOGEL GROUP
2021 · second_quarter · Q2
Issues around government support for new manufacturing operations
Issues around pandemic response efforts and domestic manufacturing
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2021 · first_quarter · Q1
Issues around pandemic response
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REALTA LIFE SCIENCES, INC. via THE VOGEL GROUP
2021 · first_quarter · 1T
Issues around healthcare technology and funding
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
DELOS LIVING, LLC via THE VOGEL GROUP
2021 · first_quarter · Q1
Issues relating to pandemic response and indoor air quality
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, White House Office
REVEN PHARMACEUTICALS, INC. via THE VOGEL GROUP
2021 · first_quarter · Q1
Issues around healthcare technologies and government funding
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COMBAT MEDICAL SYSTEMS, LLC via THE VOGEL GROUP
2021 · first_quarter · Q1
Issues around government procurement
Filing targets: Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
SMILEDIRECTCLUB via THE VOGEL GROUP
2021 · first_quarter · Q1
Issues around telehealth and industry trends
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BERKSHIRE HATHAWAY ENERGY via THE VOGEL GROUP
2021 · first_quarter · 1T
Issues relating to insurance policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEPHRON PHARMACEUTICALS CORPORATION via THE VOGEL GROUP
2021 · first_quarter · Q1
Issues around government support for new manufacturing operations
Issues around pandemic response efforts and domestic manufacturing
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
PSC BIOTECH via THE VOGEL GROUP
2021 · second_quarter · RR
Policy guidance on increasing manufacturing in the life sciences domestically
Policy guidance on increasing manufacturing in the life sciences domestically
2021 · first_quarter · RR
Terahertz technology company with potential diagnostic and clearance solutions for COVID-19 and other viruses.
SPECTRO SOLUTIONS, INC. via THE VOGEL GROUP
2021 · first_quarter · RR
Issues concerning COVID-19 diagnostics and identification
REALTA LIFE SCIENCES, INC. via THE VOGEL GROUP
2020 · fourth_quarter · Q4
Issues regarding treatments to respond to Acute Lung Injury (ALI) in COVID-19 patients.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
DELOS LIVING, LLC via THE VOGEL GROUP
2020 · fourth_quarter · Q4
Issues relating to COVID-19 response in the health and wellness industry, Safe and Healthy Workplaces during COVID-19
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, White House Office
REVEN PHARMACEUTICALS, INC. via THE VOGEL GROUP
2020 · fourth_quarter · Q4
Issues relating to business operations and growth in the biopharmaceutical industry
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COMBAT MEDICAL SYSTEMS, LLC via THE VOGEL GROUP
2020 · fourth_quarter · Q4
Issues relating to COVID-19 medical equipment supply and distribution
Filing targets: Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
SMILEDIRECTCLUB via THE VOGEL GROUP
2020 · fourth_quarter · Q4
Issues around business operations in​ the doctor-directed at-home clear aligner industry
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
BERKSHIRE HATHAWAY ENERGY via THE VOGEL GROUP
2020 · fourth_quarter · Q4
Issues relating to health care policy for employers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEPHRON PHARMACEUTICALS CORPORATION via THE VOGEL GROUP
2020 · fourth_quarter · Q4
Drug Pricing, drug shortage, drug affordability, accessibility regarding generics, vaccine development, COVID-19 PPE manufacturing
Workforce, job creation, education a manufacturing workforce, advanced manufacturing, issues on equipment
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S., White House Office
REALTA LIFE SCIENCES, INC. via THE VOGEL GROUP
2020 · third_quarter · Q3
Issues regarding treatments to respond to Acute Lung Injury (ALI) in COVID-19 patients.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
DELOS LIVING, LLC via THE VOGEL GROUP
2020 · third_quarter · Q3
Issues relating to COVID-19 response in the health and wellness industry, Safe and Healthy Workplaces during COVID-19
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, White House Office
REVEN PHARMACEUTICALS, INC. via THE VOGEL GROUP
2020 · third_quarter · Q3
Issues relating to business operations and growth in the biopharmaceutical industry
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CORIZON HEALTH via THE VOGEL GROUP
2020 · third_quarter · 3T
Issues relating to healthcare services in correctional facilities
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COMBAT MEDICAL SYSTEMS, LLC via THE VOGEL GROUP
2020 · third_quarter · Q3
Issues relating to COVID-19 medical equipment supply and distribution
Filing targets: Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
SMILEDIRECTCLUB via THE VOGEL GROUP
2020 · third_quarter · Q3
Issues around business operations in​ the doctor-directed at-home clear aligner industry
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
MEDTRADE PRODUCTS LTD via THE VOGEL GROUP
2020 · third_quarter · 3T
Issues concerning health and safety products for the military
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
BERKSHIRE HATHAWAY ENERGY via THE VOGEL GROUP
2020 · third_quarter · Q3
Issues relating to health care policy for employers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEPHRON PHARMACEUTICALS CORPORATION via THE VOGEL GROUP
2020 · third_quarter · Q3
Drug Pricing, drug shortage, drug affordability, accessibility regarding generics, vaccine development, COVID-19 PPE manufacturing
Workforce, job creation, education a manufacturing workforce, advanced manufacturing, issues on equipment
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S., White House Office
REALTA LIFE SCIENCES, INC. via THE VOGEL GROUP
2020 · third_quarter · RR
Issues regarding COVID-19 therapeutics
Issues regarding COVID-19 therapeutics
DELOS LIVING, LLC via THE VOGEL GROUP
2020 · second_quarter · Q2
Issues relating to COVID-19 response in the health and wellness industry
Filing targets: Commerce, Dept of (DOC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, Housing & Urban Development, Dept of (HUD), SENATE, White House Office
REVEN PHARMACEUTICALS, INC. via THE VOGEL GROUP
2020 · second_quarter · Q2
Issues relating to business operations and growth in the biopharmaceutical industry
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CORIZON HEALTH via THE VOGEL GROUP
2020 · second_quarter · Q2
Issues relating to healthcare services in correctional facilities
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COMBAT MEDICAL SYSTEMS, LLC via THE VOGEL GROUP
2020 · second_quarter · Q2
Issues relating to COVID-19 medical equipment supply and distribution
Filing targets: Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
SMILEDIRECTCLUB via THE VOGEL GROUP
2020 · second_quarter · Q2
Issues around business operations in​ the doctor-directed at-home clear aligner industry
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
MEDTRADE PRODUCTS LTD via THE VOGEL GROUP
2020 · second_quarter · Q2
Issues concerning health and safety products for the military
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
BERKSHIRE HATHAWAY ENERGY via THE VOGEL GROUP
2020 · second_quarter · Q2
Issues relating to health care policy for employers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEPHRON PHARMACEUTICALS CORPORATION via THE VOGEL GROUP
2020 · second_quarter · Q2
Drug Pricing, drug shortage, drug affordability, accessibility regarding generics, vaccine development, COVID-19 PPE manufacturing
Workforce, job creation, education a manufacturing workforce, advanced manufacturing, issues on equipment
Filing targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S., White House Office
DELOS LIVING, LLC via THE VOGEL GROUP
2020 · first_quarter · Q1
Issues relating to COVID-19 response in the health and wellness industry
Filing targets: Environmental Protection Agency (EPA)
REVEN PHARMACEUTICALS, INC. via THE VOGEL GROUP
2020 · first_quarter · Q1
Issues relating to business operations and growth in the biopharmaceutical industry
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CORIZON HEALTH via THE VOGEL GROUP
2020 · first_quarter · Q1
Issues relating to healthcare services in correctional facilities
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
COMBAT MEDICAL SYSTEMS, LLC via THE VOGEL GROUP
2020 · first_quarter · Q1
Issues relating to COVID-19 medical equipment supply and distribution
Filing targets: Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Vice President of the U.S.
SMILEDIRECTCLUB via THE VOGEL GROUP
2020 · first_quarter · Q1
Issues around business operations in​ the doctor-directed at-home clear aligner industry
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
MEDTRADE PRODUCTS LTD via THE VOGEL GROUP
2020 · first_quarter · Q1
Issues concerning health and safety products for the military
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
BERKSHIRE HATHAWAY ENERGY via THE VOGEL GROUP
2020 · first_quarter · Q1
Issues relating to health care policy for employers
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEPHRON PHARMACEUTICALS CORPORATION via THE VOGEL GROUP
2020 · first_quarter · Q1
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019, COVID-19 Response
Workforce, job creation, education a manufacturing workforce, advanced manufacturing, issues on equipment
Filing targets: Education, Dept of, Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
DELOS LIVING, LLC via THE VOGEL GROUP
2020 · second_quarter · RR
Issues around building awareness for Delos products and services in the health and wellness categories
Issues around building awareness for Delos products and services in the health and wellness categories
Issues around building awareness for Delos products and services in the health and wellness categories
REVEN PHARMACEUTICALS, INC. via THE VOGEL GROUP
2020 · second_quarter · RR
Issues relating to business operations and growth in the biopharmaceutical industry
Issues relating to business operations and growth in the biopharmaceutical industry
CORIZON HEALTH via THE VOGEL GROUP
2020 · second_quarter · RR
Issues relating to healthcare services in correctional facilities
Issues relating to healthcare services in correctional facilities
COMBAT MEDICAL SYSTEMS, LLC via THE VOGEL GROUP
2020 · first_quarter · RR
Issues around providing the government with medical supplies
Issues around providing the government with medical supplies
Issues around providing the government with medical supplies
SMILEDIRECTCLUB via THE VOGEL GROUP
2020 · first_quarter · RR
Issues around business operations
Issues around business operations
Issues around business operations
Issues around business operations
MEDTRADE PRODUCTS LTD via THE VOGEL GROUP
2020 · first_quarter · RR
Issues concerning health and safety products for the military
Issues concerning health and safety products for the military
BERKSHIRE HATHAWAY ENERGY via THE VOGEL GROUP
2020 · first_quarter · RR
Issues regarding healthcare policy and employee benefit packages
MAX SCHACHTER via THE VOGEL GROUP
2020 · first_quarter · RR
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019
NEPHRON PHARMACEUTICALS CORPORATION via THE VOGEL GROUP
2019 · fourth_quarter · Q4
Workforce, job creation, education a manufacturing workforce, advanced manufacturing
Drug Pricing, drug shortage, drug affordability and accessibility regarding generics, H.R. 965 - CREATES Act of 2019, H.R. 2375 - Preserve Access to Affordable Generics and Biosimilars Act, H.R. 2374 - Stop STALLING Act, H.R. 2376 - Prescription Pricing for the People Act of 2019, H.R. 1503 - Orange Book Transparency Act of 2019, H.R. 1520 - Purple Book Continuity Act of 2019
Filing targets: Education, Dept of, Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Issues around business operations
Regulations around school safety, Threat Assessment, Prevention, and Safety (TAPS) Act of 2019 (H.R. 838, S.265 - Threat Assessment, Prevention, and Safety Act of 2019, S.2779 - Luke and Alex School Safety Act of 2019